Neurocrine Biosciences NBIX
NASDAQ NBIX
$155.51 -0.02 (-0.02%)
At close: Aug 20, 2026 · 11:07 AM UTC

Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2010 - 2026)

Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - 2.55 Bn
2 Teva Pharmaceutical Industries 43.31 Bn 39.66 Bn 2.15 Bn 3.93 Bn
3 Zoetis 31.65 Bn 29.98 Bn 1.05 Bn 3.76 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn 13.44 Bn
5 United Therapeutics 22.18 Bn 19.52 Bn 683.80 Mn 1.93 Bn
6 Viatris 18.82 Bn 17.94 Bn 1.46 Bn 2.44 Bn
7 Neurocrine Biosciences 15.70 Bn 15.31 Bn 935.80 Mn 90.50 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn 1.41 Bn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - 2.96 Bn
10 Alkermes 8.21 Bn 7.55 Bn 397.90 Mn 218.28 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 90.50 Mn
Jun 30, 2026 90.50 Mn
Mar 31, 2026 90.90 Mn
Mar 31, 2026 90.90 Mn
Dec 31, 2025 89.80 Mn
Dec 31, 2025 89.80 Mn
Sep 30, 2025 97.30 Mn
Sep 30, 2025 97.30 Mn
Jun 30, 2025 91.70 Mn
Jun 30, 2025 91.70 Mn
Mar 31, 2025 87.00 Mn
Mar 31, 2025 87.00 Mn
Dec 31, 2024 82.60 Mn
Dec 31, 2024 82.60 Mn
Sep 30, 2024 80.00 Mn
Sep 30, 2024 80.00 Mn
Jun 30, 2024 80.10 Mn
Jun 30, 2024 80.10 Mn
Mar 31, 2024 75.30 Mn
Mar 31, 2024 75.30 Mn